SG11201808643SA - A solid form of (-)-ambrox formed by a bioverversion of homofarnesol in the presence of a biocatalyst - Google Patents
A solid form of (-)-ambrox formed by a bioverversion of homofarnesol in the presence of a biocatalystInfo
- Publication number
- SG11201808643SA SG11201808643SA SG11201808643SA SG11201808643SA SG11201808643SA SG 11201808643S A SG11201808643S A SG 11201808643SA SG 11201808643S A SG11201808643S A SG 11201808643SA SG 11201808643S A SG11201808643S A SG 11201808643SA SG 11201808643S A SG11201808643S A SG 11201808643SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- pct
- april
- solid form
- bioverversion
- Prior art date
Links
- YPZUZOLGGMJZJO-UHFFFAOYSA-N ambrofix Natural products C1CC2C(C)(C)CCCC2(C)C2C1(C)OCC2 YPZUZOLGGMJZJO-UHFFFAOYSA-N 0.000 title abstract 3
- YPZUZOLGGMJZJO-LQKXBSAESA-N ambroxan Chemical compound CC([C@@H]1CC2)(C)CCC[C@]1(C)[C@@H]1[C@]2(C)OCC1 YPZUZOLGGMJZJO-LQKXBSAESA-N 0.000 title abstract 3
- 239000007787 solid Substances 0.000 title abstract 3
- KOICZDDAVPYKKX-NCZFFCEISA-N (3e,7e)-4,8,12-trimethyltrideca-3,7,11-trien-1-ol Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CCO KOICZDDAVPYKKX-NCZFFCEISA-N 0.000 title abstract 2
- 102000004190 Enzymes Human genes 0.000 title abstract 2
- 108090000790 Enzymes Proteins 0.000 title abstract 2
- 239000011942 biocatalyst Substances 0.000 title abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 2
- 231100000706 no observed effect level Toxicity 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q13/00—Formulations or additives for perfume preparations
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/92—Naphthofurans; Hydrogenated naphthofurans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y504/00—Intramolecular transferases (5.4)
- C12Y504/99—Intramolecular transferases (5.4) transferring other groups (5.4.99)
- C12Y504/99017—Squalene--hopene cyclase (5.4.99.17)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Fats And Perfumes (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Furan Compounds (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
- Disinfection, Sterilisation Or Deodorisation Of Air (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2016/058997 WO2016170106A1 (en) | 2015-04-24 | 2016-04-22 | Process for isolating and purifying ambrox |
| PCT/EP2016/058987 WO2016170099A1 (en) | 2015-04-24 | 2016-04-22 | Enzymes and applications thereof |
| GBGB1618090.3A GB201618090D0 (en) | 2016-10-26 | 2016-10-26 | Product |
| PCT/EP2017/059327 WO2017182542A1 (en) | 2016-04-22 | 2017-04-20 | A solid form of (-)-ambrox formed by a bioverversion of homofarnesol in the presence of a biocatalyst |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201808643SA true SG11201808643SA (en) | 2018-11-29 |
Family
ID=57738295
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201808643SA SG11201808643SA (en) | 2016-04-22 | 2017-04-20 | A solid form of (-)-ambrox formed by a bioverversion of homofarnesol in the presence of a biocatalyst |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US10844412B2 (enExample) |
| EP (1) | EP3445755A1 (enExample) |
| JP (3) | JP7407513B2 (enExample) |
| CN (2) | CN115819385B (enExample) |
| BR (1) | BR112018071284A2 (enExample) |
| CO (1) | CO2018011292A2 (enExample) |
| GB (1) | GB201618090D0 (enExample) |
| IL (5) | IL290606B2 (enExample) |
| MX (2) | MX2018012836A (enExample) |
| RU (1) | RU2018136063A (enExample) |
| SG (1) | SG11201808643SA (enExample) |
| WO (1) | WO2017182542A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201618090D0 (en) | 2016-10-26 | 2016-12-07 | Givaudan Sa | Product |
| GB201917688D0 (en) * | 2019-12-04 | 2020-01-15 | Givaudan Sa | SHC enzymes and enzyme variants |
| GB201917694D0 (en) | 2019-12-04 | 2020-01-15 | Givaudan Sa | Enzyme mediated process |
| GB202011823D0 (en) | 2020-07-30 | 2020-09-16 | Givaudan Sa | Method |
| GB202020331D0 (en) * | 2020-12-22 | 2021-02-03 | Givaudan Sa | Process of making organic compounds |
| MX2024011115A (es) | 2022-03-17 | 2024-09-18 | Givaudan Sa | Enzimas escualeno-hopeno-ciclasa (shc) y variantes de enzimas. |
| WO2024097746A1 (en) * | 2022-11-01 | 2024-05-10 | Conagen Inc. | Alkene cyclopropanation with nickel catalyst enhancer and improved rearrangement reaction |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4123767C2 (de) * | 1991-07-18 | 1993-11-18 | Henkel Kgaa | Verfahren zur Herstellung von Stereoisomerengemischen von 8,12-Oxido-13,14,15,16-tetranorlabdan |
| EP0550889B1 (en) * | 1991-12-29 | 1996-09-18 | Kuraray Co., Ltd. | Process for producing L-Ambrox |
| DE19649655A1 (de) | 1996-11-29 | 1998-06-04 | Haarmann & Reimer Gmbh | Syntheseenzyme für die Herstellung von Coniferylalkohol, Coniferylaldehyd, Ferulasäure, Vanillin und Vanillinsäure und deren Verwendung |
| US6180121B1 (en) * | 1998-03-05 | 2001-01-30 | Colgate-Palmolive Company | Fragrance enhancing compositions for cosmetic products |
| DE19960106A1 (de) | 1999-12-14 | 2001-06-21 | Haarmann & Reimer Gmbh | Enzyme und Gene für die Herstellung von Vanillin |
| US20040265850A1 (en) | 2002-12-02 | 2004-12-30 | Hua Wang | Rapid detection of microorganisms |
| AU2003302326A1 (en) | 2002-12-02 | 2004-08-10 | The Ohio State University Research Foundation | Rapid detection of microorganisms |
| JP4598692B2 (ja) * | 2006-02-24 | 2010-12-15 | 花王株式会社 | 新規微生物、当該新規微生物を用いたドデカヒドロ−３ａ，６，６，９ａ−テトラメチルナフト［２，１−ｂ］フラン中間体の製造方法 |
| JP4156655B2 (ja) * | 2006-07-31 | 2008-09-24 | 花王株式会社 | （±）−３ａ、６、６、９ａ−テトラメチルデカヒドロナフト［２、１−ｂ］フラン−２（１Ｈ）−オン類の製造方法 |
| JP5236233B2 (ja) | 2007-09-04 | 2013-07-17 | 花王株式会社 | （−）−アンブロキサンの製造方法 |
| EP2438182B1 (de) | 2009-06-05 | 2018-10-10 | Basf Se | Biokatalytische herstellung von ambroxan |
| KR101752514B1 (ko) | 2009-06-05 | 2017-06-29 | 바스프 에스이 | 소성 변형성 강성 폴리우레탄 발포체, 접착제 및 피복재를 함유하는 복합 부품 |
| US8935839B2 (en) | 2010-02-19 | 2015-01-20 | Owen V. Burt | Ballistic enhanced battering ram |
| US8932839B2 (en) | 2010-11-17 | 2015-01-13 | Basf Se | Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein |
| ES2925777T3 (es) | 2010-11-17 | 2022-10-19 | Basf Se | Procedimiento para la ciclación biocatalítica de terpenos y mutantes de ciclasa que pueden usarse en el mismo |
| JP2013132226A (ja) | 2011-12-26 | 2013-07-08 | Kao Corp | （−）−３ａ，６，６，９ａ−テトラメチルドデカヒドロナフト［２，１−ｂ］フランの製造方法 |
| WO2013156398A1 (de) * | 2012-04-16 | 2013-10-24 | Basf Se | Verbessertes verfahren zur herstellung von (3e, 7e)-homofarnesol |
| US20130273619A1 (en) | 2012-04-16 | 2013-10-17 | Basf Se | Process for the Preparation of (3E, 7E)-Homofarnesol |
| JP6429243B2 (ja) | 2013-09-05 | 2018-11-28 | 国立大学法人 新潟大学 | アンブレインの製造方法 |
| GB201318886D0 (en) | 2013-10-25 | 2013-12-11 | Givaudan Sa | Improvements i or relating to organic compounds |
| GB201318894D0 (en) * | 2013-10-25 | 2013-12-11 | Givaudan Sa | Improvements in or relating to organic compounds |
| GB201507207D0 (en) | 2015-04-24 | 2015-06-10 | Givaudan Sa | Enzymes and applications thereof |
| GB201507170D0 (en) * | 2015-04-24 | 2015-06-10 | Givaudan Sa | Process |
| CN105037308B (zh) * | 2015-07-06 | 2017-06-06 | 四川中烟工业有限责任公司 | 一种制备降龙涎香醚的方法 |
| MX361536B (es) * | 2015-10-23 | 2018-12-10 | Univ Michoacana De San Nicolas De Hidalgo | Proceso de sintesis de ambrox a partir de ageratina jocotepecana. |
| CN105418566B (zh) * | 2015-11-27 | 2018-02-09 | 北京工商大学 | 降龙涎醚的一种合成方法 |
| GB201618090D0 (en) * | 2016-10-26 | 2016-12-07 | Givaudan Sa | Product |
-
2016
- 2016-10-26 GB GBGB1618090.3A patent/GB201618090D0/en not_active Ceased
-
2017
- 2017-04-20 IL IL290606A patent/IL290606B2/en unknown
- 2017-04-20 CN CN202211391612.9A patent/CN115819385B/zh active Active
- 2017-04-20 IL IL304330A patent/IL304330B2/en unknown
- 2017-04-20 BR BR112018071284-1A patent/BR112018071284A2/pt active Search and Examination
- 2017-04-20 MX MX2018012836A patent/MX2018012836A/es unknown
- 2017-04-20 US US16/095,444 patent/US10844412B2/en active Active
- 2017-04-20 IL IL310388A patent/IL310388B2/en unknown
- 2017-04-20 CN CN201780024917.7A patent/CN109071480B/zh active Active
- 2017-04-20 JP JP2018555127A patent/JP7407513B2/ja active Active
- 2017-04-20 IL IL320763A patent/IL320763A/en unknown
- 2017-04-20 SG SG11201808643SA patent/SG11201808643SA/en unknown
- 2017-04-20 WO PCT/EP2017/059327 patent/WO2017182542A1/en not_active Ceased
- 2017-04-20 EP EP17721968.0A patent/EP3445755A1/en active Pending
- 2017-04-20 RU RU2018136063A patent/RU2018136063A/ru not_active Application Discontinuation
-
2018
- 2018-10-15 IL IL262393A patent/IL262393B/en unknown
- 2018-10-19 MX MX2023014907A patent/MX2023014907A/es unknown
- 2018-10-22 CO CONC2018/0011292A patent/CO2018011292A2/es unknown
-
2020
- 2020-10-14 US US17/070,385 patent/US11401541B2/en active Active
-
2021
- 2021-12-20 JP JP2021205922A patent/JP7343564B2/ja active Active
-
2022
- 2022-02-25 US US17/680,840 patent/US11773419B2/en active Active
-
2023
- 2023-05-23 US US18/322,167 patent/US12084699B2/en active Active
- 2023-08-29 JP JP2023138844A patent/JP7723048B2/ja active Active
-
2024
- 2024-08-07 US US18/797,477 patent/US20240401094A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201808643SA (en) | A solid form of (-)-ambrox formed by a bioverversion of homofarnesol in the presence of a biocatalyst | |
| SG11201808476SA (en) | Recycling of polymer matrix composite | |
| SG11201808125RA (en) | Methods for solid tumor treatment | |
| SG11201811396XA (en) | Extreme ultraviolet mask blank with multilayer absorber and method of manufacture | |
| SG11201811602QA (en) | Extreme ultraviolet mask blank with alloy absorber and method of manufacture | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201803697SA (en) | Method for the economic manufacturing of metallic parts | |
| SG11201807301SA (en) | Spiro-condensed pyrrolidine derivatives as deubiquitylating enzymes (dub) inhibitors | |
| SG11201807252QA (en) | Anti-lag-3 antibodies | |
| SG11201901959YA (en) | Modified stem cell memory t cells, methods of making and methods of using same | |
| SG11201806544XA (en) | Compounds and methods of treating rna-mediated diseases | |
| SG11201807827VA (en) | Process for the preparation of pegylated drug-linkers and intermediates thereof | |
| SG11201903427UA (en) | Deodorizing agent comprising zinc neodecanoate | |
| SG11201810519XA (en) | A rinse composition, a method for forming resist patterns and a method for making semiconductor devices | |
| SG11201809830WA (en) | Selective reduction of cysteine-engineered antibodies | |
| SG11201806570SA (en) | Barrier composites | |
| SG11201903193WA (en) | Deodorant comprisng a zinc carboxylate salt and aluminium chlorohydrate | |
| SG11201901873PA (en) | Tablet compositions | |
| SG11201804163TA (en) | Method of additive manufacturing to improve interlayer adhesion | |
| SG11201903076QA (en) | Carbamoyl phenylalaninol compounds and uses therof | |
| SG11201809356YA (en) | Multilayer coating and process of preparing the multilayer coating | |
| SG11201909263XA (en) | Improvements in or relating to organic compounds | |
| SG11201806525VA (en) | Preparation of macrocyclic lactones | |
| SG11201900622UA (en) | Chemically amplified positive photoresist composition and pattern forming method using same | |
| SG11201809708PA (en) | Physiologically balanced injectable formulations of fosnetupitant |